The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medical Colleges, Cornell Tech and the New York State Agricultural Experiment Station in Geneva.

Achronix Semiconductor Corporation offers two principle product lines: a commercial line of FPGA devices named Speedster® and a specialized line of products operating near 350 MHz for use in high radiation and extreme temperature environments.Location: Santa Clara, CAFoundation Cornell Technology Licensed: 2005

AffyImmune Therapeutics

AffyImmune is an immuno-oncology company that develops T cell products for cancer therapy. The company was founded based on intellectual property generated from Weill Cornell Medicine that enables imaging of T cells in patients and T cells to specifically target tumors. The company has two products in the pipeline, and are ready to commence clinical trials in 2018Location: Natick, MAFoundation Cornell Technology Licensed: 2017songg@pillar-biosciences.com

Axium Nano is focused on the next generation of lithium-ion batteries. By incorporating a novel electrospray process to create a scalable film and adding a 2-D sheet of conductive graphene, Axium is advancing the use of silicon-based materials for efficient energy storage in batteries. Location: Los Angeles, CAFoundation Cornell Technology Licensed: 2010

Bactana Animal Health is a global development stage animal health company. Its product development platform (FPS-4) is initially being developed for food animals and has demonstrated increases in yield efficiency, weight gain, and improved gut health through enhancement to an animal’s microbiome.Location: Lewes, DEFoundation Cornell Technology Licensed: 2016john@bactana.com

Bionic Sight, LLC

Location: New York, NYFoundation Cornell Technology Licensed: 2013

BZL Biologics, Inc.

BZL Biologics, Inc., is a clinical stage company working to commercialize antibody-based therapeutics and imaging agents for prostate cancer.Location: New York, NYFoundation Cornell Technology Licensed: 1997

CycloPure is engaged in the design, development and commercialization of a new class of highly-adsorbent materials for use in the separation and removal of pollutants, VOCs and other organic compounds from water and air.Location: Encinitas, CAFoundation Cornell Technology Licensed: 2016

Fesarius Therapeutics is developing engineered tissue scaffold products for the skin and dermal layers. The products are based off the patent-pending microstructure-containing gel scaffold technology developed at Cornell. The acellular skin replacement will aim to benefit those with wounds resulting from burns, plastic surgery, tumor removal, and other forms of trauma.Location: New York, NYFoundation Cornell Technology Licensed: 2016

GrokStyle is a Cornell startup founded on home owners’ and consumers’ interest in visualizing ideas for interior design. By using a distance metrics for visual search, GrokStyle aims to provide interior design enthusiasts with an automated tool for design suggestions and ideas.Location: Ithaca, NYFoundation Cornell Technology Licensed: 2016sbell@grokstyle.com

Guangda Cooperation International Technology Center, Co, Ltd.

The company will commercialize technologies for nutraceutical and nutritional food in China.Location: Shenzhen, ChinaFoundation Cornell Technology Licensed: 2014

HµREL Corporation develops bioanalytic devices that are used in pharmaceutical development and industrial and consumer product safety testing. A HµREL® is a microfluidic circuit that models real-time protein binding, metabolism, and extraction in the liver.Location: Beverly Hills, CAFoundation Cornell Technology Licensed: 2003

HemoGenyx is a biopharmaceutical company developing a new treatment for blood diseases, such as leukemia, lymphoma and bone marrow (“BM”) failure. The Company leverages a special class of cells that can generate cancer-free, patient-matched blood stem cells.Location: Buffalo, NYFoundation Cornell Technology Licensed: 2014hemogenyx@hemogenyx.com

Immunovent, LLC is focused on the commercialization of next-generation technologies for allergy diagnosis. The company is developing the Local Allergy Mucosal Brush Test (LAMB-Dx), the first quantitative allergy diagnostic that will enable physicians to accurately test for both airborne and food allergies precisely where the clinical symptoms are occurring - in the mouth and nose.Location: New York, NYFoundation Cornell Technology Licensed: 2014info@immunovent.com

Lucerna, Inc., is a biotechnology research company focused on developing and commercializing nucleic-acid based fluorescent sensors for Point-of-Care therapeutic diagnostics and environmental biomonitoring. Lucerna also offers newly developed antibodies for proteomic research.Location: New York, NYFoundation Cornell Technology Licensed: 2010

Lumendi Ltd., is focused on the development of new minimal invasive surgical tools and devices that will provide solutions for minimally invasive gastrointestinal surgeries. The company's first product is an add-on to any commercially available endoscope that will avoid invasive colon resections to treat more complex gastrointestinal diseases.Location: London, United KingdomFoundation Cornell Technology Licensed: 2014

Metastat, Inc. (managed by Albert Einstein College of Medicine), is a life science company focused on developing and commercializing proprietary clinical diagnostic tests that predict the probability of blood borne systemic metastasis of cancer, as well as, companion therapeutics to prevent systemic metastasis.Location: The Woodlands, TXFoundation Cornell Technology Licensed: 2010

Metro Mid-Atlantic Biotech, LLC

Metro Mid-Atlantic Biotech is a development stage startup focused on developing novel small molecule therapeutics based on discoveries in the molecular mechanisms of aging and longevity in mammalian cells.Location: Birmingham, MIFoundation Cornell Technology Licensed: 2014

Novita Pharmaceuticals, Inc.

Novita Pharmaceuticals, Inc. is a biopharmaceutical startup developing target-specific small molecule drugs to treat cancer metastasis. The company is currently focusing on patients with metastatic breast cancer.Location: New York, NYFoundation Cornell Technology Licensed: 2010

NYAG (New York Apple Growers), LLC, was formed around an exclusive license agreement for two new apple varieties, 'New York 1' and 'New York 2'. This member owned company is open to all New York growers to help promote agricultural market growth within New York state.Location: Albion, NYFoundation Cornell Technology Licensed: 2010

Orthogonal, Inc., is developing environmentally safe, high-performance fluorinated photoresists to make "organic," or carbon-based electronics on the same machinery manufacturers use to make silicon-based electronics.Location: Ithaca, NYFoundation Cornell Technology Licensed: 2009

Prendismo, LLC, is home to the world's premiere collection of digital video content on business, leadership, and entrepreneurship. Prendismo arose from the eClips project at Cornell University and the Cornell Center for Technology Enterprise (CCTEC).Location: Ithaca, NYFoundation Cornell Technology Licensed: 2008

ReconnectNEURO, LLC

ReconnectNEURO is focused on the treatment of cognitive impairment through the use of deep brain stimulation methods. The stimulation systems work to increase consciousness in patients who are minimally conscious or who have reduced capacity due to trauma, stroke, or other diseases.Location: Claymont, DEFoundation Cornell Technology Licensed: 2016

SafetyStratus, Inc., is a cloud computing company that distributes software on a subscription basis to research institutions. The company's application, LabcliQ, is used for workflow and laboratory inspections.Location: Ithaca, NYFoundation Cornell Technology Licensed: 2011

Telescope Time, Inc., also known as Slooh, provides online sharing of space photos and partners with Google Sky to map the universe and co-promote live astronomy.Location: Washington, CTFoundation Cornell Technology Licensed: 2012

Tetragenetics, Inc. (managed by University of Georgia Research Foundation, Inc.), is an early stage biotechnology company developing an alternative technology platform for the production of genetically engineered proteins for the treatment and prevention of human and animal disease.Location: Ithaca, NYFoundation Cornell Technology Licensed: 2005

Vernx Biotechnology is developing a range of nutrition products using branched fatty acids (BCFA) for multiple uses: to improve gastrointestinal health in pre-mature and non-premature infants, as a nutritional supplement for adults, and for eventual therapeutic use. Location: New South Wales, AustraliaFoundation Cornell Technology Licensed: 2016

VitaScan Technologies has developed a smartphone based diagnostic platform enabling accurate, fast, convenient, and low cost testing of vitamins and micronutrients in the home and at local pharmacies and clinics.Location: Ithaca, NYFoundation Cornell Technology Licensed: 2016li@vitametech.com

Xallent is developing the next generation of Scanning Probe Microscopes (SPM) to enable advanced, rapid, in-line testing of semiconductor devices and thin-films at the micro- and nano-scales. Patented technologies are based on integrating one or multiple tips with supporting sensing, actuation and electronics on a single probe chip. These “probe platforms-on-a-chip” are designed and fabricated using advanced nanoelectromechanical system (NEMS) technologies, enabling simple and cost-effective miniaturization to the nanoscale.Location: Ithaca, NYFoundation Cornell Technology Licensed: 2015

XyloCor is a clinical-stage biotechnology company dedicated to developing first-in-class gene therapies for patients with cardiovascular disease. The company's lead product comprises the use of vascular endothelial growth factor for the treatment of diffuse coronary artery disease.Location: New York, NYFoundation Cornell Technology Licensed: 2015

Appinions, Inc.

Appinions, Inc., is an opinions-powered platform that makes it easy to identify, analyze, monitor, and engage with influencers. This platform features an extensive database that includes millions of opinions extracted from blogs, Twitter, Facebook, forums, newspaper and magazine articles, and radio and television transcripts. Appinions was acquired by ScribbleLive in 2015.Location: New York, NYFoundation Cornell Technology Licensed: 2007

Phytex, LLC, produces phytase enzymes for an animal feed product called OptiPhos. This product enables poultry and pigs to absorb more phosphorus from their feed grain, creating substantially less phosphorus in their waste. Phytex was acquired by Huvepharma in 2013.Location: Portland, MEFoundation Cornell Technology Licensed: 2000